Financial reports
10-K
2023 FY
Annual report
27 Feb 24
10-K/A
2022 FY
Annual report (amended)
22 Dec 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
Current reports
8-K
Zai Lab Announces Full-Year 2023
27 Feb 24
8-K
Entry into a Material Definitive Agreement
8 Feb 24
8-K
Zai Lab Announces Third Quarter 2023
7 Nov 23
8-K
Zai Lab Announces Second Quarter 2023
7 Aug 23
8-K
Zai Lab Announces Promotion of Yajing Chen to Chief Financial Officer
6 Jul 23
8-K
Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China
30 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
20 Jun 23
8-K
Other Events
6 Jun 23
8-K
Zai Lab Announces First Quarter 2023
9 May 23
8-K
Other Events
31 Mar 23
Registration and prospectus
F-6EF
Automatic registration for ADRs (foreign)
14 Jul 23
S-8
Registration of securities for employees
28 Oct 22
S-8
Registration of securities for employees
9 May 22
424B3
Prospectus supplement
30 Mar 22
S-8
Registration of securities for employees
9 Aug 21
424B5
Prospectus supplement for primary offering
21 Apr 21
424B5
Prospectus supplement for primary offering
19 Apr 21
S-3ASR
Automatic shelf registration
19 Apr 21
424B5
Prospectus supplement for primary offering
23 Sep 20
424B5
Prospectus supplement for primary offering
16 Sep 20
Proxies
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
18 Apr 23
DEFA14A
Additional proxy soliciting materials
20 May 22
DEFA14A
Additional proxy soliciting materials
2 May 22
DEF 14A
Definitive proxy
2 May 22
PRE 14A
Preliminary proxy
22 Apr 22
DEFA14A
Additional proxy soliciting materials
23 Mar 22
DEF 14A
Definitive proxy
28 Feb 22
PRE 14A
Preliminary proxy
11 Feb 22
DEFA14A
Additional proxy soliciting materials
30 Apr 21
Other
UPLOAD
Letter from SEC
10 Jun 22
UPLOAD
Letter from SEC
10 Jun 22
CORRESP
Correspondence with SEC
3 May 22
UPLOAD
Letter from SEC
19 Apr 22
CORRESP
Correspondence with SEC
14 Jan 22
CORRESP
Correspondence with SEC
17 Dec 21
UPLOAD
Letter from SEC
10 Dec 21
CORRESP
Correspondence with SEC
9 Nov 21
UPLOAD
Letter from SEC
29 Sep 21
SEC STAFF
SEC staff action: Order
30 Oct 20
Ownership
4
Rafael Amado
19 Mar 24
4
Frazor Titus Edmondson III
19 Mar 24
4
Ying Du
15 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
4
Joshua L Smiley
4 Mar 24
SC 13G
Capital World Investors
12 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
SC 13G
WELLINGTON MANAGEMENT GROUP LLP
8 Feb 24
SC 13G/A
Invesco Ltd.
1 Feb 24